View Older Stories View More Recent Stories

Sep 28, 2026 08:00AM Argus Starts 10X Genomics (TXG) at Buy
Sep 24, 2026 06:00PM Torex Gold Provides Q3 2026 Morelos Drilling & Exploration Update
Sep 8, 2026 07:00AM 10X Genomics (TXG) Reiterated at Buy by Stifel as MuSpAn Bioinformatics Package Launches
Sep 1, 2026 02:13AM RBC Capital Starts 10X Genomics (TXG) at Sector Perform
Aug 28, 2026 02:41PM Jury finds Parse Biosciences willfully infringed 10x Genomics patents
Aug 10, 2026 05:19AM 10X Genomics (TXG) PT Raised to $60 at Canaccord
Aug 6, 2026 04:22PM 10x Genomics (TXG) Tops Q2 EPS by 10c, Beats on Revenue
Jul 1, 2026 08:39AM 10X Genomics (TXG) PT Raised to $42 at Piper Sandler
Jun 17, 2026 09:02AM 10x Genomics and Cleveland Clinic team up on bladder cancer research
Jun 10, 2026 10:50AM TD Cowen notes short interest shifts in life science tools stocks
Jun 10, 2026 06:50AM Canaccord Reiterates Buy Rating on 10X Genomics (TXG)
May 7, 2026 04:29PM 10x Genomics (TXG) Misses Q1 EPS by 4c
Apr 20, 2026 05:23AM 10X Genomics (TXG) PT Raised to $30 at BofA Securities
Mar 30, 2026 05:42PM William Blair Upgrades 10X Genomics (TXG) to Outperform
Mar 25, 2026 07:01AM Bioptimus launches STELA spatial biology atlas with 10x Genomics partnership
Mar 17, 2026 08:56AM TD Cowen: 'MSFT's AI-Powered Spatial Product Weakens Spatial Exposed Stocks'
Mar 2, 2026 09:04AM 10X Genomics (TXG) PT Raised to $25 at Stifel on Solid New Product Adoption
Feb 13, 2026 09:00AM 10X Genomics (TXG) PT Raised to $22 at Canaccord Genuity
Feb 12, 2026 04:12PM 10x Genomics (TXG) Tops Q4 EPS by 9c, provides guidance
Feb 4, 2026 09:03AM 10x Genomics partners with UK consortium for cancer research
Jan 27, 2026 06:22AM 10X Genomics (TXG) PT Lowered to $20 at Leerink Partners
Jan 12, 2026 09:12AM 10x Genomics partners with Brigham & Women's for autoimmune study
Jan 12, 2026 09:10AM 10x Genomics partners with Dana-Farber for cancer diagnostics research
Jan 12, 2026 04:20AM 10X Genomics (TXG) PT Raised to $21 at BofA Securities
Jan 7, 2026 07:10AM CareDx partners with 10x Genomics on transplant rejection research program
Dec 1, 2025 04:24PM Morgan Stanley Assumes 10X Genomics (TXG) at Equalweight Citing Reasonable Valuation
Nov 14, 2025 06:11AM 10x Genomics names Randy Wu as general counsel, Eric Whitaker retires
Nov 6, 2025 04:35PM 10x Genomics (TXG) Tops Q3 EPS by 7c, Beats on Revenue; Offers Q4 Revenue Guidance
Oct 29, 2025 09:01AM 10x Genomics launches enhanced Chromium Flex assay for single cell research
Oct 20, 2025 12:31PM 10x Genomics partners with Anthropic to integrate analysis tools into Claude
Sep 11, 2025 03:49AM Piper Sandler Starts 10X Genomics (TXG) at Neutral
Aug 19, 2025 09:02AM 10x Genomics launches Xenium Protein for RNA and protein analysis
Aug 7, 2025 04:28PM 10x Genomics (TXG) Tops Q2 EPS by 65c, provides guidance
Jul 1, 2025 06:40AM Canaccord Genuity Reiterates Buy Rating on 10X Genomics (TXG)
May 27, 2025 08:00PM Citi names 3 stocks as its new top picks in the Life Science sector
May 14, 2025 04:05PM 10x Genomics (TXG) Announces Patent Litigation Settlement Agreement with Bruker
May 12, 2025 05:24AM 10X Genomics (TXG) PT Lowered to $15 at Canaccord Genuity
May 8, 2025 04:12PM 10x Genomics (TXG) Tops Q1 EPS by 19c, provides guidance
Mar 3, 2025 04:13PM 10x Genomics (TXG) Secures Injunction Against Parse Biosciences' Planned ATAC Products
Feb 26, 2025 02:46PM 10x Genomics (TXG) 999 contracts of August 17.50 calls trade
Feb 13, 2025 06:40AM 10X Genomics (TXG) PT Lowered to $20 at Citi
Feb 13, 2025 06:37AM 10X Genomics (TXG) PT Lowered to $18 at Canaccord Genuity
Feb 12, 2025 04:14PM 10x Genomics (TXG) Misses Q4 EPS by 9c, provides guidance
Jan 13, 2025 08:48AM 10x Genomics (TXG) Announces Preliminary Select Fourth Quarter and Full Year 2024 Results
Dec 23, 2024 04:06PM U.S. District Court Awards 10x Genomics (TXG) Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products
Oct 30, 2024 06:20AM Canaccord Genuity Reiterates Buy Rating on 10X Genomics (TXG)
Oct 29, 2024 04:12PM 10x Genomics (TXG) Tops Q3 EPS by 4c, Misses on Revenue; Offers FY24 Revenue Guidance
Oct 16, 2024 08:27AM TD Cowen Reiterates Hold Rating on 10X Genomics (TXG)
Oct 10, 2024 08:22AM TD Cowen Reiterates Hold Rating on 10X Genomics (TXG)
Oct 10, 2024 06:17AM 10X Genomics (TXG) PT Lowered to $20 at Canaccord Genuity
View More Recent Stories View Older Stories